As of January 29, 2025, the average one-year price target for Compass is $7.59/share. The forecasts range from a low of $5.56 to a high of $10.50. The average price target represents an increase of ...
Fintel reports that on April 2, 2025, Leerink Partners upgraded their outlook for Compass Therapeutics (NasdaqCM:CMPX) from Market Perform to Outperform. As of March 19, 2025, the average one-year ...
Fintel on MSN
UBS Upgrades Compass (COMP)
Fintel reports that on February 11, 2025, UBS upgraded their outlook for Compass (NYSE:COMP) from Neutral to Buy. Analyst Price Forecast Suggests 2.79% Upside As of January 29, 2025, the average ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results